LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion into the US market Gerresheimer has been investing significantly in expanding its operations in the United States, particularly in Georgia, with the addition of production capacity for inhalers, auto injectors, and offices. This expanding presence in the US market presents a sales opportunity for partnerships with local healthcare providers and pharmaceutical companies.

Innovative product launches Recent product launches like the Gx Elite vials and the Gx Inbeneo autoinjector platform showcase Gerresheimer's commitment to innovation and quality in pharmaceutical containment solutions. Leveraging these innovative products, sales teams can target pharmaceutical, biotech, and cosmetic companies looking to enhance their product offerings with state-of-the-art packaging solutions.

Strong financial backing With revenues around $2 billion and recent investments of $180 million into production capacity, Gerresheimer demonstrates financial stability and growth. Business development professionals can leverage this financial strength to negotiate large-scale contracts with healthcare organizations and drug manufacturers requiring reliable and well-funded partners.

Strategic partnerships with healthcare providers Gerresheimer's focus on safety and quality in drug delivery systems presents an opportunity for forming strategic partnerships with healthcare providers who prioritize patient well-being. Sales representatives can tailor proposals to emphasize how Gerresheimer's solutions can enhance patient safety and adherence, making them an attractive partner for healthcare institutions.

Market positioning in North America Through investments to strengthen its market position, particularly in North America, Gerresheimer is poised to capture a larger share of the pharmaceutical and healthcare market in the region. Sales development representatives can capitalize on this strategic positioning to target clients seeking reliable and established partners for their containment solutions and medical devices needs.

Similar companies to Gerresheimer

Gerresheimer Tech Stack

Gerresheimer uses 8 technology products and services including Usercentrics, Dell, BEM, and more. Explore Gerresheimer's tech stack below.

  • Usercentrics
    Cookie Compliance
  • Dell
    IT Infrastructure
  • BEM
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • Meister
    Project Management
  • Paylocity
    Recruitment Marketing
  • Gutenberg
    Web Platform Extensions
  • IIS
    Web Servers

Media & News

Gerresheimer's Email Address Formats

Gerresheimer uses at least 1 format(s):
Gerresheimer Email FormatsExamplePercentage
F.Last@gerresheimer.comJ.Doe@gerresheimer.com
58%
First.Last@gerresheimer.comJohn.Doe@gerresheimer.com
41%
First.Middle@gerresheimer.comJohn.Michael@gerresheimer.com
1%

Frequently Asked Questions

Where is Gerresheimer's headquarters located?

Minus sign iconPlus sign icon
Gerresheimer's main headquarters is located at Klaus-Bungert-Str. 4 Düsseldorf, 40468 DE. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Gerresheimer's phone number?

Minus sign iconPlus sign icon
You can contact Gerresheimer's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Gerresheimer's official website and social media links?

Minus sign iconPlus sign icon
Gerresheimer's official website is gerresheimer.com and has social profiles on LinkedIn.

How much revenue does Gerresheimer generate?

Minus sign iconPlus sign icon
As of October 2024, Gerresheimer's annual revenue reached $5B.

What is Gerresheimer's SIC code NAICS code?

Minus sign iconPlus sign icon
Gerresheimer's SIC code is 3221 - Glass Containers NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Gerresheimer have currently?

Minus sign iconPlus sign icon
As of October 2024, Gerresheimer has approximately 10K employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer Business Manager: D. K.Chief Executive Officer: D. S.Chief Executive Officer: K. T.. Explore Gerresheimer's employee directory with LeadIQ.

What industry does Gerresheimer belong to?

Minus sign iconPlus sign icon
Gerresheimer operates in the Pharmaceutical Manufacturing industry.

What technology does Gerresheimer use?

Minus sign iconPlus sign icon
Gerresheimer's tech stack includes UsercentricsDellBEMWindows ServerMeisterPaylocityGutenbergIIS.

What is Gerresheimer's email format?

Minus sign iconPlus sign icon
Gerresheimer's email format typically follows the pattern of . Find more Gerresheimer email formats with LeadIQ.

How much funding has Gerresheimer raised to date?

Minus sign iconPlus sign icon
As of October 2024, Gerresheimer has raised $298M in funding. The last funding round occurred on Apr 18, 2023 for $298M.

When was Gerresheimer founded?

Minus sign iconPlus sign icon
Gerresheimer was founded in 1864.
Gerresheimer

Gerresheimer

Pharmaceutical ManufacturingDüsseldorf, Germany10001+ Employees

About Gerresheimer
Gerresheimer is an innovative systems and solutions provider and a global partner to the pharma, biotech, and cosmetics industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, infusion, dropper and syrup bottles, and more. With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated revenues of around €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6). 

Über Gerresheimer 
Gerresheimer ist als innovativer System- und Lösungsanbieter der globale Partner für die Pharma-, Biotech- und Kosmetikbranche. Das Unternehmen bietet ein umfassendes Portfolio von Containment Solutions für Medikamente, Drug-Delivery-Systemen und Medizinprodukten sowie Lösungen für die Gesundheitsbranche an. Das Leistungsspektrum umfasst unter anderem digitale Lösungen für die Therapiebegleitung, Medikamentenpumpen, Spritzen, Pens, Autoinjektoren und Inhalatoren sowie Injektionsfläschchen, Ampullen, Tablettenbehälter, Infusions-, Tropf- und Sirupflaschen. Gerresheimer sorgt dafür, dass Medikamente sicher zum Patienten gelangen und zuverlässig verabreicht werden können.
Mit 35 Produktionsstandorten in 16 Ländern in Europa, Amerika und Asien ist Gerresheimer weltweit präsent und produziert vor Ort für die regionalen Märkte. Mit rund 12.000 Mitarbeitenden erwirtschaftete das Unternehmen 2023 einen Umsatz von rund 2 Mrd. Euro. Die Gerresheimer AG notiert im MDAX an der Frankfurter Wertpapierbörse (ISIN: DE000A0LD6E6).

 

Section iconCompany Overview

Headquarters
Klaus-Bungert-Str. 4 Düsseldorf, 40468 DE
Phone number
SIC Code
3221 - Glass Containers
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1864
Employees
10001+

Section iconFunding & Financials

  • $298M

    Gerresheimer has raised a total of $298M of funding over 1 rounds. Their latest funding round was raised on Apr 18, 2023 in the amount of $298M.

  • $1B

    Gerresheimer's revenue is in the range of $1B

Section iconFunding & Financials

  • $298M

    Gerresheimer has raised a total of $298M of funding over 1 rounds. Their latest funding round was raised on Apr 18, 2023 in the amount of $298M.

  • $1B

    Gerresheimer's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.